In addition, studies of PLK1 expression and tumor stage have revealed that its expression is positively correlated with the clinical stage of NSCLC14, colon cancer47, prostate cancer48, endometrial cancer52, breast cancer50, and ovarian cancer53. This evidence concerns the gene PLK1 and neoplasm.